Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

3 AI Stocks to Buy Under $10 in August 2023

By Ian Cooper, InvestorPlace Contributor
The bull market in artificial intelligence is just getting started, creating big opportunity for this list of AI stocks under $10.

TTOO Stock Alert: T2 Biosystems Jumps on Nasdaq Extension

By Shrey Dua, InvestorPlace Senior Financial News Reporter
TTOO stock is up 8% today on news that T2 Biosystems has been given until Nov. 20 to regain Nasdaq compliance.

Why Is TG Therapeutics (TGTX) Stock Down 50% Today?

By Josh Enomoto, InvestorPlace Contributor
Although anticipation ran hot for TG Therapeutics’ flagship MS therapeutic, a disappointing Q2 print cratered TGTX stock.

3 Cheap Healthcare Stocks That Smart Investors Will Snap Up Now

By Joel Baglole, InvestorPlace Contributor
While technology stocks have powered this year's market rally, shares of healthcare companies have trailed behind. The S&P 500 Healthcare Index is essentially flat year-to-date (down 0.71%) while the benchmark S&P 500 has gained 20% on the year.

Why Is OKYO Pharma (OKYO) Stock Down 19% Today?

By William White, InvestorPlace Writer
OKYO Pharma (OKYO) stock is falling on Tuesday even after the biopharmaceutical company withdrew a public offering of its shares.

Looking for a Bargain? 7 Blue-Chip Stocks to Buy That Are Down 5% in 2023

By Muslim Farooque, InvestorPlace Contributor
These discounted blue-chip stocks boast robust underlying businesses which present amazing long-term upside potential ahead

Looking for a Bargain? 3 Biotech Stocks to Buy That Are Down 20%-60% in 2023

By Larry Ramer, InvestorPlace Contributor
Since the pharmaceutical sector is very lucrative in America, these biotech stock bargains can be very profitable. 

3 Hidden Penny Stocks That Could Turn $100 into $10,000

By Omor Ibne Ehsan
These penny stocks have multibagger upside potential with great margins of safety, according to Wall Street analysts.

Why Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today?

By William White, InvestorPlace Writer
Sonnet BioTherapeutics (SONN) stock is taking a beating on Monday after the company announced details for a public stock offering.

Why Is Navidea Biopharmaceutical (NAVB) Stock Down 13% Today?

By William White, InvestorPlace Writer
Navidea Biopharmaceutical (NAVB) stock is falling on Monday after the biopharmaceutical company got a major delisting warning.

7 Healthcare Stocks to Ditch Before They Make Your Portfolio Sick

By Louis Navellier and the InvestorPlace Research Staff
For investors who choose wisely, profits in healthcare stocks can be spectacular. But the losses can also be dramatic if you choose poorly.

3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes

By Larry Ramer, InvestorPlace Contributor
Here are three millionaire maker drug stocks from companies whose drugs could make truly staggering profits.

3 Cannabis Stocks to Buy Before the Breakout

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor
Cannabis is an industry that has been overlooked for some time. Investors can begin buying these cannabis stocks poised for a breakout.

Biotech Battlefields: 3 Stocks to Watch Amid Wall Street Turmoil

By John Blankenhorn, InvestorPlace Contributor
There is opportunity in a crisis. Key biotech stocks amid turmoil could be the greatest deals on the market today.

3 Biotech Stocks to Buy Before the Breakout

By Michael Que, InvestorPlace Contributor
Explosive growth and rapid innovation lie ahead for these three biotechnology stocks, making them the ones to watch.

3 Biotech Stocks to Buy Before Drug Trials End

By John Blankenhorn, InvestorPlace Contributor
Drug trials are a chance for high risk, high reward investing. These stocks doing neurodegenerative trials could be set for big gains.

Why Is Reata Pharmaceuticals (RETA) Stock Up 53% Today?

By William White, InvestorPlace Writer
Reata Pharmaceuticals (RETA) stock is soaring higher on Friday as investors react to an acquisition deal with Biogen (BIIB).

Why Is Tonix Pharmaceuticals (TNXP) Stock Down 43% Today?

By William White, InvestorPlace Writer
Tonix Pharmaceuticals (TNXP) stock is taking a beating on Friday after the company announced a $7 million public stock offering.

Why Is SIGA Technologies (SIGA) Stock Up 31% Today?

By William White, InvestorPlace Writer
SIGA Technologies (SIGA) stock is soaring higher on Friday after the pharmaceutical company secured a #138 million government order.
Load More Articles